|
Vantage Oncology at Redhawk Radiation Therapy Center TO OPEN EARLY FEBRUARY New Center Marks $4 Million Investment in State-of-the-Art Technology and Facility TEMECULA, Calif. (January 26, 2006) – The new Vantage Oncology at Redhawk Radiation Therapy Center will be opening its doors to patients in Temecula in early February. Vantage Oncology Inc., an El Segundo, Calif.-based developer and operator of state-of-the-art radiation oncology centers, has invested approximately $4 million in the most advanced technology and comfortable facilities in the new center located in the Redhawk Medical Building on Highway 79 in Temecula. Valley Radiotherapy Associates (VRA) will provide professional services in the center. The new technology which includes a Varian Clinac iX Linear Accelerator with On Board Imaging capability, a General Electric CT Simulator, and the Varian Eclipse Planning System, brings patients increased access to advanced treatment options, including Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT) and Respiratory Gating. Dr. Mary Ann Rose, who has served for two years as Medical Director of Vantage Oncology at Wildomar Radiation Therapy Center, will assume leadership of the new facility. In addition, Dr. Brian Ronson has recently been recruited from Loma Linda to serve the community in connection with the expansion. “I look forward to continuing to work with Dr. Ronson to provide cancer patients in the Temecula Valley with the most advanced technology and services in a comfortable and caring environment," said Dr. Rose. “Cancer continues to affect hundreds of thousands of people every year and, as a patient, you want a team of experts that is dedicated to helping you beat this disease," said Michael T. Fiore, CEO of Vantage Oncology. “It is our mission to provide a standard of care for cancer patients that is unequalled by other facilities." About Vantage Oncology, Inc. Founded in May 2002, Vantage Oncology, Inc. develops, acquires and operates state-of-the-art radiation oncology centers. El Segundo, Calif.-based Vantage Oncology is led by a seasoned management team, including Chief Executive Officer Michael Fiore, Chief Medical Officer Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. Vantage Oncology was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies and was funded by Conning Capital Partners, New Enterprise Associates, Versant Ventures and Salix Ventures. For more information about Vantage Oncology, visit www.vantageoncology.com. About Valley Radiotherapy Associates Medical Group, Inc. Valley Radiotherapy Associates Medical Group, Inc. (VRA) was founded by Leslie E. Botnick, M.D. and Christopher M. Rose, M.D. in June 1983 to deliver radiation oncology services. Today, El Segundo, Calif.-based VRA has 30 board-certified radiation oncologists and provides advanced radiation therapy services to communities at 17 hospitals and freestanding centers in Los Angeles, Orange, Riverside, Imperial Valley and San Bernardino Counties in California; Denver and Vail, Colorado; and Santa Fe, New Mexico. VRA has distinguished itself during the past 20 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about VRA, visit www.valley-radiotherapy.com # # # RADIATION THERAPY UPGRADES COMPLETE IN RIVERSIDE Vantage Oncology Upgrades Facility and Radiation Therapy Equipment at Vantage Oncology at Riverside Radiation Therapy Center Increasing Patient Access to State-of-the-Art Treatments RIVERSIDE, Calif. (February 22, 2006) –Vantage Oncology, Inc., an El Segundo, Calif.-based developer and operator of state-of-the-art radiation oncology centers, announced that it has completed facility and equipment upgrades to its Vantage Oncology at Riverside Radiation Therapy Center. Vantage Oncology has committed an investment of $3 million in new radiation treatment equipment and facility upgrades. The state-of-the-art technology brings patients increased access to advanced treatment options and includes a Varian Clinac© 21 EX Linear Accelerator in addition to its existing Varian 2100C Linear Accelerator, a Varian Varis Record and Verify System and a Varian Eclipse Treatment Planning System. Simulations are performed on a GE CT Scanner. The center can treat patients with Intensity Modulated Radiation Therapy (IMRT), 3D Conformal radiation therapy and High Dose Rate (HDR) Brachytherapy. These advanced clinical treatment options permit precise targeting of radiation to a tumor, sparing critical normal organs, providing for better outcomes and fewer side effects for patients. The facility upgrades include a cancer education center that is now open and available to the public. Ramez Farah, M.D., Chief Medical Officer of Vantage Oncology at Riverside Radiation Therapy Center, has been providing physician services at the center since 2000. He has expertise in IMRT with a special interest in the treatment of gynecological cancers using High Dose Rate (HDR) Brachytherapy. Dr. Farah works with the support of Valley Radiotherapy Associates Medical Group (VRA), which provides professional clinical services to many Vantage Oncology centers and has been a leader in radiation oncology in Southern California for more than 20 years. “We are pleased to provide the Riverside area with increased access to the latest in radiation therapy technology," said Michael Fiore, Chief Executive Officer of Vantage Oncology. “Those who receive treatment at our newly renovated Riverside center can expect to be provided with superior care in a convenient and comfortable setting." “VRA is dedicated to supporting Dr. Farah and providing Riverside with the highest quality patient care," said Leslie Botnick, M.D., Chief Medical Officer of Vantage Oncology and President of VRA. “Vantage Oncology’s commitment to providing the latest technology for the treatment of cancer, in combination with the collective expertise and experience of our physicians in Riverside and the greater Inland Empire area, will allow us to continue our mission of providing patients with access to the most advanced clinical treatment options." Vantage Oncology’s four radiation oncology centers located in Riverside, San Bernardino, Temecula and Wildomar greatly benefit health plans, referring physicians, and their patients, by providing comprehensive radiation therapy services to the Inland Empire. About Vantage Oncology, Inc. Founded in May 2002, Vantage Oncology, Inc. develops, acquires and operates state-of-the-art radiation oncology centers. El Segundo, Calif.-based Vantage Oncology is led by a seasoned management team, including Chief Executive Officer Michael Fiore, Chief Medical Officer Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. Vantage Oncology was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies and was funded by CCP Equity Partners, New Enterprise Associates, Versant Ventures and Salix Ventures. For more information about Vantage Oncology, visit www.vantageoncology.com. About Valley Radiotherapy Associates Medical Group, Inc. Valley Radiotherapy Associates Medical Group, Inc. (VRA) was founded by Leslie E. Botnick, M.D. and Christopher M. Rose, M.D. in June 1983 to deliver radiation oncology services. Today, El Segundo, Calif.-based VRA has 30 board-certified radiation oncologists and provides advanced radiation therapy services to communities at 17 hospitals and freestanding centers in Los Angeles, Orange, Riverside, Imperial Valley and San Bernardino Counties in California; Denver and Vail, Colorado; and Santa Fe, New Mexico. VRA has distinguished itself during the past 20 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about VRA, visit www.valley-radiotherapy.com. # # # VANTAGE ONCOLOGY INC. COMPLETES UPGRADES TO IMPERIAL VALLEY CANCER CENTER EL CENTRO, Calif. (January 23, 2006) Vantage Oncology Inc. has completed its upgrades to its recently acquired Vantage Oncology at Imperial Valley Cancer Center. The center will begin offering patients these new services in mid February. Vantage Oncology, an El Segundo, Calif.-based developer and operator of state-of-the-art radiation oncology centers, has invested over $1.5 million in new radiation treatment equipment and facility upgrades for the center. The center offers therapeutic and diagnostic services including Intensity Modulated Radiation Therapy (IMRT) and 16 slice CT Imaging. IMRT is an advanced clinical treatment option that permits precise targeting of radiation to a tumor, sparing critical normal tissues, providing for better outcomes and fewer side effects for patients. The Center will continue to work with local physicians and providers to offer patients excellent service and care. Jedidiah Monson, M.D. continues to provide full time radiation therapy services at the center. He is a member of the nationally recognized radiation oncology practice, Valley Radiotherapy Associates. Hasnat Ahmed, M.D., who has been with the Center since its inception, will continue to provide hematology and medical oncology services as an independent practitioner. “I look forward to working with Dr. Ahmed to continue providing our cancer patients in the Imperial Valley with the most current technology and services in a comfortable and caring environment," said Dr. Monson. “The upgrades to the center will enable us to provide patients academic quality medicine along with the latest technology to treat cancers more accurately and aggressively," said Leslie Botnick, M.D., Chief Medical Officer of Vantage Oncology and President/CEO of VRA. “Cancer continues to affect millions of people every year and as a patient you want a team of experts that is dedicated to helping you beat this disease. I am confident we have assembled a team of experts that can effectively educate and treat the patients who have entrusted us with their health." “We are grateful for this opportunity to enhance existing capabilities to provide state-of-the-art radiation therapy," said Michael T. Fiore, CEO of Vantage Oncology. “It is our mission to deliver compassionate and innovative care to every patient who walks through our doors." About Vantage Oncology, Inc. Founded in May 2002, Vantage Oncology, Inc. develops, acquires and operates state-of-the-art radiation oncology centers. El Segundo, Calif.-based Vantage Oncology is led by a seasoned management team, including Chief Executive Officer Michael Fiore, Chief Medical Officer Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. Vantage Oncology was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies and was funded by Conning Capital Partners, New Enterprise Associates, Versant Ventures and Salix Ventures. For more information about Vantage Oncology, visit www.vantageoncology.com. About Valley Radiotherapy Associates Medical Group, Inc. Valley Radiotherapy Associates Medical Group, Inc. (VRA) was founded by Leslie E. Botnick, M.D. and Christopher M. Rose, M.D. in June 1983 to deliver radiation oncology services. Today, El Segundo, Calif.-based VRA has 30 board-certified radiation oncologists and provides advanced radiation therapy services to communities at 17 hospitals and freestanding centers in Los Angeles, Orange, Riverside, Imperial Valley and San Bernardino Counties in California; Denver and Vail, Colorado; and Santa Fe, New Mexico. VRA has distinguished itself during the past 20 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about VRA, visit www.valleyradiotherapy.com. About Imperial Valley Cancer Center Imperial Valley Cancer Center has been providing cancer patients and their families with medical and radiation oncology and CT imaging services since its inception in 1998. Staffed by caring and proficient professionals, Imperial Valley Cancer Center prides itself on offering advanced technologies and techniques to residents of the Imperial Valley, who no longer have to travel to San Diego, California or Yuma, Arizona to receive the best possible care. # # # EVANSVILLE CANCER CENTER / VANTAGE ONCOLOGY ANNOUNCES ACCREDITATION BY THE AMERICAN COLLEGE OF RADIATION ONCOLOGY Once Again Evansville Cancer Center Has Been Awarded a Seal of Approval for Exceeding National Standards of Excellence in Cancer Care Evansville, Ind. (March 1, 2006) – Evansville Cancer Center / Vantage Oncology was recently awarded its accreditation by the prestigious American College of Radiation Oncology (ACRO). The Practice Accreditation Program, developed by ACRO, is a voluntary process in which professional peers recognize facilities that meet or exceed standards of excellence in cancer care. The standards set forth by the program, which regularly undergo peer review, ensure that medical personnel are well qualified through education and certification in their respective fields of expertise. In addition, the facility must have the appropriate equipment to provide optimal care and must exceed safety guidelines established by ACRO. “To be awarded this accreditation is a great honor and a result of the commitment that Vantage Oncology and the Evansville Cancer Center have made to excellent care," said Al Korba, M.D., Medical Director of the center. “Having all the necessary elements to provide world-class care for our patients, remains a priority at the Evansville Cancer Center." The center currently offers pain and palliative services, diagnostic imaging, an on-site lab, cancer registry and a full-time psychologist. In addition, it offers High Dose Rate (HDR) Brachytherapy, an internationally recognized Gamma Med program and Intensity Modulated Radiation Therapy (IMRT). These advanced clinical treatment options permit precise targeting of radiation to a tumor, sparing critical normal organs, providing for better outcomes and fewer side effects for patients. Evansville Cancer Center / Vantage Oncology is located at 700 North Burkhardt Road. For more information, please call 812-474-6000, or visit www.evansvillecancercenter.com. About Vantage Oncology, Inc. Founded in May 2002, Vantage Oncology, Inc. develops, acquires and operates state-of-the-art radiation oncology centers. El Segundo, Calif.-based Vantage Oncology is led by a seasoned management team, including Chief Executive Officer Michael Fiore, Chief Medical Officer Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. Vantage Oncology was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies and was funded by CCP Equity Partners, New Enterprise Associates, Versant Ventures and Salix Ventures. For more information about Vantage Oncology, visit www.vantageoncology.com. |